1. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. Issue 6 (June 2022) Authors: Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, Mar... Journal: Lancet Issue: Volume 9:Issue 6(2022) Page Start: e403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) Database. Issue 4 (31st August 2022) Authors: McCurdy, Arleigh; Louzada, Martha; Venner, Christopher P.; Visram, Alissa; Masih‐Khan, Esther; Kardjadj, Moustafa; Jimenez‐Zepeda, Victor H.; LeBlanc, Richard; Sebag, Michael; Song, Kevin; White, Darrell; Mian, Hira; Stakiw, Julie; Reiman, Anthony; Aslam, Muhammad; Kotb, Rami; Gul, Engin; Reece, ... Journal: EJHaem Issue: Volume 3:Issue 4(2022) Page Start: 1252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Issue 8 (August 2016) Authors: Kumar, Shaji; Paiva, Bruno; Anderson, Kenneth C; Durie, Brian; Landgren, Ola; Moreau, Philippe; Munshi, Nikhil; Lonial, Sagar; Bladé, Joan; Mateos, Maria-Victoria; Dimopoulos, Meletios; Kastritis, Efstathios; Boccadoro, Mario; Orlowski, Robert; Goldschmidt, Hartmut; Spencer, Andrew; Hou, Jian; Ch... Journal: Lancet oncology Issue: Volume 17:Issue 8(2016:Aug.) Page Start: e328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial. Issue 10292 (19th June 2021) Authors: Moreau, Philippe; Dimopoulos, Meletios-Athanasios; Mikhael, Joseph; Yong, Kwee; Capra, Marcelo; Facon, Thierry; Hajek, Roman; Špička, Ivan; Baker, Ross; Kim, Kihyun; Martinez, Gracia; Min, Chang-Ki; Pour, Ludek; Leleu, Xavier; Oriol, Albert; Koh, Youngil; Suzuki, Kenshi; Risse, Marie-Laure; Asset... Journal: Lancet Issue: Volume 397:Issue 10292(2021) Page Start: 2361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database. (5th April 2022) Authors: LeBlanc, Richard; Mian, Hira; Reece, Donna; Masih‐Khan, Esther; Kardjadj, Moustafa; Jimenez‐Zepeda, Victor H.; McCurdy, Arleigh; Song, Kevin; Sebag, Michael; Louzada, Martha; White, Darrell; Stakiw, Julie; Kotb, Rami; Reiman, Anthony; Aslam, Muhammad; Gul, Engin; Venner, Christopher P. Journal: British journal of haematology Issue: Volume 198:Number 1(2022) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Real‐world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database. (26th September 2022) Authors: Mian, Hira; LeBlanc, Richard; Louzada, Martha; Masih‐Khan, Esther; McCurdy, Arleigh; Venner, Christopher P.; Stakiw, Julie; Kardjadj, Moustafa; Jimenez‐Zepeda, Victor H.; Sebag, Michael; White, Darrell; Aslam, Muhammad; Song, Kevin; Reiman, Anthony; Kotb, Rami; Gul, Engin; Reece, Donna Journal: Cancer medicine Issue: Volume 12:Number 4(2023) Page Start: 4357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Retrospective study of treatment patterns and outcomes post‐lenalidomide for multiple myeloma in Canada. (27th June 2021) Authors: Reece, Donna E.; Masih‐Khan, Esther; Atenafu, Ehetu G.; Jimenez‐Zepeda, Victor H.; McCurdy, Arleigh; Song, Kevin; LeBlanc, Richard; Sebag, Michael; White, Darrell; Cherniawsky, Hannah; Reiman, Anthony; Stakiw, Julie; Louzada, Martha L.; Kotb, Rami; Aslam, Muhammad; Gul, Engin; Venner, Christopher P. Journal: European journal of haematology Issue: Volume 107:Number 4(2021) Page Start: 416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219. (July 2019) Authors: Melosky, Barbara; Bradbury, Penelope; Tu, Dongsheng; Florescu, Marie; Reiman, Anthony; Nicholas, Garth; Basappa, Naveen; Rothenstein, Jeffrey; Goffin, John R.; Laurie, Scott A.; Wheatley-Price, Paul; Leighl, Natasha; Goss, Glenwood; Reaume, M. Neil; Butts, Charles; Murray, Nevin; Card, Cynthia; K... Journal: Lung cancer Issue: Volume 133(2019) Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The future of myeloma research in Canada and beyond: results of a James Lind Alliance priority setting partnership. (6th November 2021) Authors: Fowler, Samantha; McLaughlin, Lauren; Bridges, Sarah; Robichaud, Marc; Ridgway, Barbara; Reece, Donna; Song, Kevin; Dalrymple, Lorelei; Sully, Robin; Nason, Sharon; Rowland, Suzanne; MacDonald, Trish; Paine, William; Reiman, Anthony Journal: British journal of haematology Issue: Volume 196:Number 5(2022) Page Start: e52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The impact of lenalidomide maintenance on second‐line chemotherapy in transplant eligible patients with multiple myeloma. (16th February 2021) Authors: Cherniawsky, Hannah M.; Kukreti, Vishal; Reece, Donna; Masih‐Khan, Esther; McCurdy, Arleigh; Jimenez‐Zepeda, Victor H.; Sebag, Michael; Song, Kevin; White, Darrell; Stakiw, Julie; LeBlanc, Richard; Reiman, Anthony; Louzada, Martha; Aslam, Muhammad; Kotb, Rami; Gul, Engin; Atenafu, Eshetu; Venner,... Journal: European journal of haematology Issue: Volume 106:Number 5(2021) Page Start: 673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗